Trial Profile
A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan 160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Cilnidipine/valsartan (Primary) ; Cilnidipine; Valsartan
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Ildong Pharmaceutical
- 22 Mar 2014 New trial record